ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jarle Vaage
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaage, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaage, J.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2004;78:1658
© 2004 The Society of Thoracic Surgeons

INVITED COMMENTARY

Jarle Vaage, MD, PhD

Department of Surgery, Ulleval University Hospital, Oslo, Norway 0407

i.j.vaage@ioks.uio.no

The first 20% of the full text of this article appears below.

The role of insulin, glucose-insulin, and glucose-insulin-potassium therapy as an adjunct to protection in relation to myocardial ischemia, cardioplegia, and so forth, has been controversial, although there have been several proponents of this as an important part of myocardial protection. The studies performed all have their weaknesses, in particular the number of patients included has been too low.

The present meta-analysis is a huge work and an interesting attempt to get a perspective on this controversy: . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.